Cargando…
Cancer Cell Membrane-Coated Nanosuspensions for Enhanced Chemotherapeutic Treatment of Glioma
Effective intracerebral delivery is key for glioma treatment. However, the drug delivery system within the brain is largely limited by its own adverse physical and chemical properties, low targeting efficiency, the blood–brain barrier and the blood–brain tumor barrier. Herein, we developed a simple,...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400986/ https://www.ncbi.nlm.nih.gov/pubmed/34443689 http://dx.doi.org/10.3390/molecules26165103 |
_version_ | 1783745443776167936 |
---|---|
author | Fan, Yueyue Hao, Wenyan Cui, Yuexin Chen, Mengyu Chu, Xiaoyang Yang, Yang Wang, Yuli Gao, Chunsheng |
author_facet | Fan, Yueyue Hao, Wenyan Cui, Yuexin Chen, Mengyu Chu, Xiaoyang Yang, Yang Wang, Yuli Gao, Chunsheng |
author_sort | Fan, Yueyue |
collection | PubMed |
description | Effective intracerebral delivery is key for glioma treatment. However, the drug delivery system within the brain is largely limited by its own adverse physical and chemical properties, low targeting efficiency, the blood–brain barrier and the blood–brain tumor barrier. Herein, we developed a simple, safe and efficient biomimetic nanosuspension. The C6 cell membrane (CCM) was utilized to camouflaged the 10-hydroxycamptothecin nanosuspension (HCPT-NS) in order to obtain HCPT-NS/CCM. Through the use of immune escape and homotypic binding of the cancer cell membrane, HCPT-NS/CCM was able to penetrate the blood–brain barrier and target tumors. The HCPT-NS is only comprised of drugs, as well as a small amount of stabilizers that are characterized by a simple preparation method and high drug loading. Similarly, the HCPT-NS/CCM is able to achieve targeted treatment of glioma without any ligand modification, which leads it to be stable and efficient. Cellular uptake and in vivo imaging experiments demonstrated that HCPT-NS/CCM is able to effectively cross the blood–brain barrier and was concentrated at the glioma site due to the natural homing pathway. Our results reveal that the glioma cancer cell membrane is able to promote drug transport into the brain and enter the tumor via a homologous targeting mechanism. |
format | Online Article Text |
id | pubmed-8400986 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84009862021-08-29 Cancer Cell Membrane-Coated Nanosuspensions for Enhanced Chemotherapeutic Treatment of Glioma Fan, Yueyue Hao, Wenyan Cui, Yuexin Chen, Mengyu Chu, Xiaoyang Yang, Yang Wang, Yuli Gao, Chunsheng Molecules Article Effective intracerebral delivery is key for glioma treatment. However, the drug delivery system within the brain is largely limited by its own adverse physical and chemical properties, low targeting efficiency, the blood–brain barrier and the blood–brain tumor barrier. Herein, we developed a simple, safe and efficient biomimetic nanosuspension. The C6 cell membrane (CCM) was utilized to camouflaged the 10-hydroxycamptothecin nanosuspension (HCPT-NS) in order to obtain HCPT-NS/CCM. Through the use of immune escape and homotypic binding of the cancer cell membrane, HCPT-NS/CCM was able to penetrate the blood–brain barrier and target tumors. The HCPT-NS is only comprised of drugs, as well as a small amount of stabilizers that are characterized by a simple preparation method and high drug loading. Similarly, the HCPT-NS/CCM is able to achieve targeted treatment of glioma without any ligand modification, which leads it to be stable and efficient. Cellular uptake and in vivo imaging experiments demonstrated that HCPT-NS/CCM is able to effectively cross the blood–brain barrier and was concentrated at the glioma site due to the natural homing pathway. Our results reveal that the glioma cancer cell membrane is able to promote drug transport into the brain and enter the tumor via a homologous targeting mechanism. MDPI 2021-08-23 /pmc/articles/PMC8400986/ /pubmed/34443689 http://dx.doi.org/10.3390/molecules26165103 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Fan, Yueyue Hao, Wenyan Cui, Yuexin Chen, Mengyu Chu, Xiaoyang Yang, Yang Wang, Yuli Gao, Chunsheng Cancer Cell Membrane-Coated Nanosuspensions for Enhanced Chemotherapeutic Treatment of Glioma |
title | Cancer Cell Membrane-Coated Nanosuspensions for Enhanced Chemotherapeutic Treatment of Glioma |
title_full | Cancer Cell Membrane-Coated Nanosuspensions for Enhanced Chemotherapeutic Treatment of Glioma |
title_fullStr | Cancer Cell Membrane-Coated Nanosuspensions for Enhanced Chemotherapeutic Treatment of Glioma |
title_full_unstemmed | Cancer Cell Membrane-Coated Nanosuspensions for Enhanced Chemotherapeutic Treatment of Glioma |
title_short | Cancer Cell Membrane-Coated Nanosuspensions for Enhanced Chemotherapeutic Treatment of Glioma |
title_sort | cancer cell membrane-coated nanosuspensions for enhanced chemotherapeutic treatment of glioma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400986/ https://www.ncbi.nlm.nih.gov/pubmed/34443689 http://dx.doi.org/10.3390/molecules26165103 |
work_keys_str_mv | AT fanyueyue cancercellmembranecoatednanosuspensionsforenhancedchemotherapeutictreatmentofglioma AT haowenyan cancercellmembranecoatednanosuspensionsforenhancedchemotherapeutictreatmentofglioma AT cuiyuexin cancercellmembranecoatednanosuspensionsforenhancedchemotherapeutictreatmentofglioma AT chenmengyu cancercellmembranecoatednanosuspensionsforenhancedchemotherapeutictreatmentofglioma AT chuxiaoyang cancercellmembranecoatednanosuspensionsforenhancedchemotherapeutictreatmentofglioma AT yangyang cancercellmembranecoatednanosuspensionsforenhancedchemotherapeutictreatmentofglioma AT wangyuli cancercellmembranecoatednanosuspensionsforenhancedchemotherapeutictreatmentofglioma AT gaochunsheng cancercellmembranecoatednanosuspensionsforenhancedchemotherapeutictreatmentofglioma |